home / stock / bvxv / bvxv quote
Last: | $1.36 |
---|---|
Change Percent: | -0.76% |
Open: | $1.32 |
Close: | $1.36 |
High: | $1.37 |
Low: | $1.32 |
Volume: | 22,721 |
Last Trade Date Time: | 09/06/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.36 | $1.32 | $1.36 | $1.37 | $1.32 | 22,721 | 09-06-2023 |
$1.31 | $1.35 | $1.31 | $1.35 | $1.31 | 3,226 | 09-05-2023 |
$1.305 | $1.36 | $1.305 | $1.37 | $1.3 | 3,499 | 09-04-2023 |
$1.305 | $1.36 | $1.305 | $1.37 | $1.3 | 3,499 | 09-01-2023 |
$1.35 | $1.34 | $1.35 | $1.3585 | $1.31 | 8,519 | 08-31-2023 |
$1.34 | $1.36 | $1.34 | $1.37 | $1.34 | 3,926 | 08-30-2023 |
$1.36 | $1.37 | $1.36 | $1.37 | $1.35 | 12,704 | 08-29-2023 |
$1.37 | $1.31 | $1.37 | $1.39 | $1.31 | 57,649 | 08-28-2023 |
$1.3194 | $1.29 | $1.3194 | $1.32 | $1.29 | 2,832 | 08-25-2023 |
$1.32 | $1.34 | $1.32 | $1.34 | $1.305 | 2,104 | 08-24-2023 |
$1.3 | $1.26 | $1.3 | $1.3231 | $1.26 | 7,503 | 08-23-2023 |
$1.27 | $1.31 | $1.27 | $1.31 | $1.25 | 18,545 | 08-22-2023 |
$1.32 | $1.32 | $1.32 | $1.358 | $1.32 | 16,879 | 08-21-2023 |
$1.35 | $1.305 | $1.35 | $1.35 | $1.305 | 12,222 | 08-18-2023 |
$1.31 | $1.3 | $1.31 | $1.31 | $1.3 | 1,776 | 08-17-2023 |
$1.3 | $1.3005 | $1.3 | $1.3085 | $1.3 | 8,485 | 08-16-2023 |
$1.31 | $1.3 | $1.31 | $1.31 | $1.3 | 5,490 | 08-15-2023 |
$1.3 | $1.3001 | $1.3 | $1.3088 | $1.3 | 26,102 | 08-14-2023 |
$1.3 | $1.36 | $1.3 | $1.3601 | $1.3 | 17,668 | 08-11-2023 |
$1.32 | $1.3 | $1.32 | $1.3398 | $1.3 | 9,561 | 08-10-2023 |
News, Short Squeeze, Breakout and More Instantly...
BiondVax Pharmaceuticals Ltd. Company Name:
BVXV Stock Symbol:
NASDAQ Market:
BiondVax (NASDAQ: BVXV) , a biotechnology company, today announced a change of its corporate name to Scinai Immunotherapeutics, which will debut on the Nasdaq under a new symbol, SCNI, on Sept. 7, 2023. In the past two years, the company has revamped its senior management team and pharmaceuticals...
JERUSALEM, Sept. 06, 2023 (GLOBE NEWSWIRE) -- via IBN -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) , a biopharmaceutical company, is pleased to announce today a change of its corporate name to Scinai Immunotherapeutics Ltd. (“Scinai ”). In the past two years, the Company ...
BiondVax (NASDAQ: BVXV) , a biotechnology company that recently signed an exclusive worldwide license to develop and commercialize innovative alpaca-derived nanosized antibodies (“NanoAbs”) targeting IL-17 cytokines as treatments for psoriasis and psoriatic arthritis, recently recei...